Dyslipidemia in patients with chronic and end-stage kidney disease

Jad Omran, Ashraf Al-Dadah, Kevin C Dellsperger

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.

Original languageEnglish (US)
Pages (from-to)165-177
Number of pages13
JournalCardioRenal Medicine
Volume3
Issue number3
DOIs
StatePublished - Jan 1 2013

Fingerprint

Dyslipidemias
Chronic Kidney Failure
Chronic Renal Insufficiency
Population
Clinical Trials
Lipids
Therapeutics

Keywords

  • Chronic kidney disease
  • Dyslipidemia
  • End-stage renal disease
  • Oxidized low-density lipoprotein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Urology

Cite this

Dyslipidemia in patients with chronic and end-stage kidney disease. / Omran, Jad; Al-Dadah, Ashraf; Dellsperger, Kevin C.

In: CardioRenal Medicine, Vol. 3, No. 3, 01.01.2013, p. 165-177.

Research output: Contribution to journalReview article

Omran, J, Al-Dadah, A & Dellsperger, KC 2013, 'Dyslipidemia in patients with chronic and end-stage kidney disease', CardioRenal Medicine, vol. 3, no. 3, pp. 165-177. https://doi.org/10.1159/000351985
Omran, Jad ; Al-Dadah, Ashraf ; Dellsperger, Kevin C. / Dyslipidemia in patients with chronic and end-stage kidney disease. In: CardioRenal Medicine. 2013 ; Vol. 3, No. 3. pp. 165-177.
@article{b38ef11e94694a93bda309d71d6bf038,
title = "Dyslipidemia in patients with chronic and end-stage kidney disease",
abstract = "In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.",
keywords = "Chronic kidney disease, Dyslipidemia, End-stage renal disease, Oxidized low-density lipoprotein",
author = "Jad Omran and Ashraf Al-Dadah and Dellsperger, {Kevin C}",
year = "2013",
month = "1",
day = "1",
doi = "10.1159/000351985",
language = "English (US)",
volume = "3",
pages = "165--177",
journal = "CardioRenal Medicine",
issn = "1664-3828",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Dyslipidemia in patients with chronic and end-stage kidney disease

AU - Omran, Jad

AU - Al-Dadah, Ashraf

AU - Dellsperger, Kevin C

PY - 2013/1/1

Y1 - 2013/1/1

N2 - In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.

AB - In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.

KW - Chronic kidney disease

KW - Dyslipidemia

KW - End-stage renal disease

KW - Oxidized low-density lipoprotein

UR - http://www.scopus.com/inward/record.url?scp=84896703533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896703533&partnerID=8YFLogxK

U2 - 10.1159/000351985

DO - 10.1159/000351985

M3 - Review article

AN - SCOPUS:84896703533

VL - 3

SP - 165

EP - 177

JO - CardioRenal Medicine

JF - CardioRenal Medicine

SN - 1664-3828

IS - 3

ER -